Title : Efficacy and safety of DBPR108 monotherapy in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled, phase II clinical trial.

Pub. Date : 2020 Jul

PMID : 32338063






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Objective: DBPR108, a novel dipeptidyl-peptidase-4 inhibitor, has shown great antihyperglycemic effect in animal models. DBPR-108 dipeptidyl peptidase 4 Homo sapiens